UPS: The Margin Story the Filings Tell vs. the One the Market Is Buying
A stock trading at a trailing earnings multiple well above its own decade average. A business whose net margin has...
Tonix’s TONMYA sales nearly triple in Q2 as payer coverage reaches 43% of U.S. lives
Tonix Pharmaceuticals reported second-quarter 2026 net sales of approximately $11 million for TONMYA, its fibromyalgia treatment, represent
Evidence Sheet: Dow (DOW)
The standing BullScope yardsticks for Dow, computed from official filings and refreshed with each new edition.
Honeywell Broke Itself in Three. The Price Hasn’t Decided What to Think Yet.
A single-digit earnings multiple is what the market assigns to a business in slow decline. A mid-single-digit sales multiple is...
Disney’s Numbers Say One Thing. The Stock Price Says Another.
Six years ago, Disney was the most expensive media stock on earth, and investors were happy to pay for the...
AbbVie: Two Drugs Are Doing the Work of an Entire Company
Three years ago, AbbVie's biggest drug lost its U.S. patent protection and the company braced for a revenue cliff. Humira,...
GE Aerospace: The Engine Is Running Hot, and the Factory Floor Is Struggling to Keep Up
In one breath The Q2 2026 10-Q shows revenue up sharply and a backlog worth more than four years of...
Evidence Sheet: American Airlines Group (AAL)
The standing BullScope yardsticks for American Airlines Group, computed from official filings and refreshed with each new edition.
The jobs number shrank. The unemployment rate fell. Both are true, and that’s the problem.
In one breath The U.S. economy shed 23,000 jobs in July 2026, according to the BLS report released August 7,...
Evidence Sheet: Eli Lilly & (LLY)
The standing BullScope yardsticks for Eli Lilly &, computed from official filings and refreshed with each new edition.
BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.